State of Wyoming raised its stake in shares of Sotera Health Company (NASDAQ:SHC – Free Report) by 78.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 140,479 shares of the company’s stock after buying an additional 61,862 shares during the period. Sotera Health comprises about 0.2% of State of Wyoming’s investment portfolio, making the stock its 29th biggest holding. State of Wyoming’s holdings in Sotera Health were worth $2,014,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also modified their holdings of SHC. PNC Financial Services Group Inc. increased its stake in shares of Sotera Health by 10.8% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,204 shares of the company’s stock worth $127,000 after acquiring an additional 705 shares during the last quarter. Strs Ohio boosted its position in Sotera Health by 17.4% during the fourth quarter. Strs Ohio now owns 4,895 shares of the company’s stock valued at $86,000 after purchasing an additional 727 shares during the last quarter. Federated Hermes Inc. boosted its position in Sotera Health by 6.0% during the fourth quarter. Federated Hermes Inc. now owns 16,676 shares of the company’s stock valued at $294,000 after purchasing an additional 944 shares during the last quarter. First Citizens Bank & Trust Co. grew its stake in Sotera Health by 1.5% in the fourth quarter. First Citizens Bank & Trust Co. now owns 66,266 shares of the company’s stock valued at $1,169,000 after purchasing an additional 970 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its stake in Sotera Health by 1.7% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 64,993 shares of the company’s stock valued at $1,146,000 after purchasing an additional 1,061 shares in the last quarter. 91.03% of the stock is currently owned by hedge funds and other institutional investors.
Sotera Health Trading Down 0.6%
Sotera Health stock opened at $17.29 on Thursday. Sotera Health Company has a one year low of $11.00 and a one year high of $19.85. The company’s fifty day moving average price is $16.57 and its two-hundred day moving average price is $16.39. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. The company has a market capitalization of $4.93 billion, a price-to-earnings ratio of 42.17 and a beta of 1.76.
Insiders Place Their Bets
In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 15.36% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on SHC shares. Piper Sandler reaffirmed an “overweight” rating and set a $22.00 price target (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Weiss Ratings raised Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Wall Street Zen downgraded Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Barclays increased their price objective on Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Finally, UBS Group set a $19.00 price objective on shares of Sotera Health in a research report on Wednesday, June 24th. Eight equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $20.25.
Check Out Our Latest Stock Analysis on Sotera Health
About Sotera Health
Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.
Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.
Featured Articles
- Five stocks we like better than Sotera Health
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding SHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sotera Health Company (NASDAQ:SHC – Free Report).
Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.
